Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azarga added to prostaglandin monotherapy in open-angle glaucoma
2009-010101-36Phase 4Completed
- Sponsor
- Alcon Inc.
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of brinzolamide in open-angle glaucoma (OAG) and pigmentary glaucoma (PG), sponsored by Alcon Inc. Primary endpoint: Mean intraocular pressure decrease at Month 3. Started Mar 2009; status: completed.
02
Drugs
brinzolamide
03
Conditions
open-angle glaucoma (OAG)pigmentary glaucoma (PG)
Beyond the preview
Go deeper on 2009-010101-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010101-36.